SERA PROGNOSTICS, INC. (SERA) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$1.96

From 52W high−43.90%

Volume7938.00

Market cap$81.66M

P/E (TTM)—

P/S (TTM)1166.6x

Div yield—

Key dataNov 4, 2026

Open

$1.96

From 52W high

−43.90%

Volume

7938.00

Market cap

$81.66M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.2x

P/E (TTM)

—

RSI (14)

48.7

MomentumView details →

1D Return

+7.25%

YTD Return

−31.53%

SummaryUpdated Jun 1, 2026

Sera Prognostics, Inc. (NASDAQ:SERA) is a women's health diagnostic company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in July 2021 and focuses on developing blood-based biomarker tests to predict and improve pregnancy outcomes. Sera Prognostics operates in the specialized field of prenatal diagnostics, addressing one of healthcare's most pressing challenges: preterm birth, which affects approximately 1 in 10 babies born in the United States and has seen rates increase by 12% between 2014-2022.

Ask drillr about SERA PROGNOSTICS, INC. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.2x

EV/Sales

545.9x

P/S (TTM)

1166.6x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

−150.00%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−55.97%

ROA (TTM)

−38.31%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−35.19%

EPS YoY

+21.18%

FCF YoY

−4.46%

Revenue CAGR 3Y

−32.89%

EPS CAGR 3Y

+32.32%

EBITDA YoY

−1.59%

MomentumView details →

1D Return

+7.25%

YTD Return

−31.53%

1Y Return

−34.63%

RSI (14)

48.7

vs 50D SMA

−1.12%

vs 200D SMA

−4.13%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

1.98x

Quick Ratio

1.98x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.18

EPS Surprise

−16.72%

Beats (12Q)

7/12

Next Q EPS Est

−$0.17

Avg Surprise (4Q)

2.35%

Rev Surprise

−57.97%

Financials snapshotView financials →

Revenue (TTM)

70000.00

Net Income (TTM)

−33.23M

Op. CF (TTM)

−27.68M

Next earningsNov 4, 2026 →

Latest newsMore news →

Sera Prognostics, Inc. announced the appointment of Scott Gleason as Chief Financial Officer and Treasurer, effective August 31, 2026.78d ago

Similar companies

Atlantic International Corp.ATLN China Health Group Inc.08225.HK Burning Rock Biotech LimitedBNR Biosino Bio-Technology & Science Inc.08247.HK Star Equity Holdings, Inc.STRR Precipio, Inc.PRPO Find similar companies →

Latest newsMore news →

SERA PROGNOSTICS, INC. announced that it will report its third-quarter fiscal 2026 financial results after market close on November 4, 2026, and host a conference call and live webcast at 5:00 p.m.14d ago Sera Prognostics, Inc. announced the appointment of Scott Gleason as Chief Financial Officer and Treasurer, effective August 31, 2026.78d ago